FDA Extends Electronic Submission Deadline for Type III Drug Master Files

International Pharmaceutical Regulatory Monitor
A A
The FDA issued final guidance on electronic submissions of drug master files, giving sponsors of Type III DMFs for packaging materials an extra year before submission requirements kick in.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor